Federal Supply Schedule 36F79721D0180
Award Date
6/1/21
Last Date to Order
5/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Ulai Health LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned, small disadvantaged business. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and enables the VA to procure a wide range of pharmaceutical and hematology-related products from the vendor. The $2,225,000 multiple-award contract has a period of performance through June 14, 2026. As a Federal Supply Schedule contract, it...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, provides for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2026. The prime contractor, Unipack LLC (doing business as US Pharmaceuticals), is a minority-owned, for-profit manufacturer of goods. The contract is a multiple...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded to Haleon US LP, a for-profit manufacturer, with a ceiling value of $9,867,650.00 and a period of performance through September 30, 2026. The FSS contract, categorized under Schedule 65 IB, aims to provide the VA's VISN 12 with a wide...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract award to Shield Therapeutics Inc. by the Department of Veterans Affairs (VA) is for the provision of pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The $225,000 ceiling value contract has a base period of performance through March 14, 2027. As a multiple award schedule, this contract allows the VA and other eligible federal agencies to procure the contracted pharmaceuticals and related hematology...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Luye Pharma USA LTD, a foreign-owned for-profit organization. The $25,000 contract is for an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The period of performance runs from the award date of April 3, 2025 through September 30, 2025. No set-asides were used, and...